News

Share

Updates matching "Access to Affordable Cancer Drugs"

HHS Hears Cancer Patients’ Concerns About Timely Access to Drug Therapies in Medicare Part D

May 16, 2019
National

Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ‘six protected classes’ of cancer, epilepsy, HIV/AIDS, mental illness and organ transplants.

Television and Digital Ad Campaign Calls on HHS Secretary Azar to Stop Proposed Changes to ‘Six Protected Classes’

May 14, 2019
National

The American Cancer Society Cancer Action Network (ACS CAN) launched an ad campaign this week highlighting deep concerns from cancer patients and survivors over the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on their access to critical drug therapies.

New Survey: Utilization Management Delays Cancer Care; Leads to More Stress and Contributes to Worse Outcomes

March 28, 2019
National

A new nationwide survey of cancer patients, caregivers and doctors details the negative effects insurance utilization management policies in private insurance have had on patient care and what those policies could mean should proposed changes to Medicare’s Part D’s “six protected classes” prescription drug coverage policy go into effect.

Strengthening Nation’s Health Care System Should Be a Priority in State of the Union Address

February 5, 2019
National

Cancer patients, survivors and caregivers will tune into the president’s State of the Union address to see if the president will commit to strengthen the nation's health care system, support life-saving medical research and improve quality of life for patients.

ACS CAN and Nearly 60 Patient Advocacy Groups Send Letter Raising Alarm Over Changes to Medicare Part D Cancer Drug Coverage

January 28, 2019
National

On Friday the American Cancer Society Cancer Action Network (ACS CAN) along with nearly 60 other patient advocacy organizations sent a letter to the Department of Health and Human Services (HHS) about how proposed changes to Medicare Part D’s six protected classes could hurt cancer patients’ timely access to drug

ACS CAN Letter: Proposed Changes to Medicare Drug Coverage Could Delay Cancer Patients’ Access to Treatment

January 25, 2019
National

Today the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Department Health and Human Services (HHS) detailing ways in which proposed changes to Medicare Part D’s six protected classes could jeopardize cancer patients’ timely access to drug therapies.

2019 Day at the State Capitol

January 23, 2019
Virginia

Volunteers from across Virginia visited the State Capitol on January 21 in an effort to make their voices heard in the fight against cancer! The day began with a legislative briefing that included a visit from State Delegate Glenn Davis. The volunteers then conducted individual meetings with their state legislators

Proposed regulation could put cancer therapies out of reach for patients on Medicare Part D plans

January 17, 2019
National

The administration has proposed a policy change to Medicare Part D that could have devastating consequences for cancer patients on Medicare. These proposed changes could have wide-ranging impact as currently 43 million American seniors rely on Medicare Part D plans for their prescription drug coverage. The proposed changes could allow

Ad Campaign Highlights Broad Patient and Provider Opposition to Proposed Medicare Changes

January 16, 2019
National

The American Cancer Society Cancer Action Network (ACS CAN) is launching a new print and digital ad campaign today emphasizing the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on patients’ access to affordable drug therapies.